REGENERON PHARMACEUTICALS, INC. (REGN) Earnings History
3 quarters held2/8 transcripts analyzed2/15 figures attested
Connect your agentPeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$4.3B+16.7%$1.3B$12.23Jul 30, 2026
Earnings call · Jul 30, 2026
| Q2 FY26 | YoY | 6M FY26 | |
|---|---|---|---|
| Revenue | $4.3B1 | +16.7% | – |
| Net income | $1.3B | -6.8% | $2.0B |
| Op income | $1.3B | +19.8% | $1.9B |
| EPS (dil.) | $12.23 | -4.5% | – |
| EPS (basic) | $12.62 | -4.7% | – |
| Gross margin | 78.0% | -5.0pp | |
| Op margin | 30.1% | +0.8pp | |
| Net margin | 30.2% | -7.6pp |
- [1] “Total revenues $ 4,291 $ 3,676 17 %” view source
Guidance & outlook
Management guidance
Q2 2026fy_current
other
6.5B—6.6B
other
6.0B—6.0B
other
2.8B—3.0B
other
2.5B—2.6B
gross_margin_pct
78.0%—79.0%
gross_margin_pct
84.0%—85.0%
other
985M—1.0B
other
970M—1.0B
capex
1.0B—1.1B
other
13—14
other
14—15
Special items & operational metrics
Operational metrics
Q2 2026Dupixent global net sales
5998.2M
+38.0% YoY
Prior year: 4344.6M
USD
EYLEA U.S. net sales
412.2M
-45.3% YoY
Prior year: 754.3M
USD
Libtayo global net sales
489.4M
+30.0% YoY
Prior year: 376.5M
USD
EYLEA HD U.S. net sales
596.3M
+51.9% YoY
Prior year: 393.2M
USD
Q1 2026$3.6B+19.0%$727.0M$6.75Apr 29, 2026
Earnings call · Apr 29, 2026
| Q1 FY26 | YoY | |
|---|---|---|
| Revenue | $3.6B1 | +19.0% |
| Net income | $727.0M | -10.1% |
| Op income | $642.9M | +8.7% |
| EPS (dil.) | $6.75 | -7.2% |
| EPS (basic) | $6.99 | -7.8% |
| Gross margin | 76.0% | -5.0pp |
| Op margin | 17.8% | -1.7pp |
| Net margin | 20.2% | -6.5pp |
- [1] “Total revenues $ 3,605 $ 3,029 19 %” view source
Q4 2025$238.0M–$845.0M$7.86Jan 30, 2026
| Q4 FY25 | YoY | FY25 | |
|---|---|---|---|
| Revenue | $238.0M | – | – |
| Net income | $845.0M | -8.0% | $4.5B |
| Op income | $879.9M | -11.1% | $3.6B |
| EPS (dil.) | $7.86 | -2.5% | – |
| EPS (basic) | – | – | – |
| Gross margin | 81.0% | -3.0pp | |
| Op margin | 22.7% | -3.5pp | |
| Net margin | 21.7% | -2.5pp |
Filing coverage
57 filings indexed · 44,148 XBRL facts| Filing | Date | Period | Sections | Tables |
|---|---|---|---|---|
| 8-K | 2026-07-30 | Q2 2026 | 9 | 0 |
| 10-Q | 2026-07-30 | – | 41 | 89 |
| 8-K | 2026-07-06 | Q2 2026 | 5 | 0 |
| 8-K | 2026-06-17 | – | 1 | 0 |
| 10-Q | 2026-04-29 | – | 41 | 85 |
| 8-K | 2026-04-29 | Q1 2026 | 9 | 0 |
| DEF 14A | 2026-04-24 | – | 12 | 0 |
| 8-K | 2026-04-08 | Q1 2026 | 5 | 0 |
| 10-K | 2026-02-04 | FY | 64 | 119 |
| 8-K | 2026-01-30 | Q4 2025 | 12 | 0 |
Showing the latest 10 of 57 — the full set is in the API.